48,860
edits
(11 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
[[Image:Lung adenocarcinoma - pleural fluid -- very high mag.jpg|thumb|right|250px|Adenocarcinoma (lung). Pleural fluid specimen. [[Pap stain]]. (WC)]] | |||
[[Image:Colorectal adenocarcinoma cytology low mag.jpg|thumb|right|250px|Adenocarcinoma (colorectal). [[Field stain]]. (WC)]] | |||
[[Image:Colorectal adenocarcinoma -- high mag.jpg|thumb|right|250px|[[Colorectal adenocarcinoma]]. [[H&E stain]]. (WC)]] | |||
'''Adenocarcinoma''' is a form of [[cancer]] that arises from glandular tissue. Adenocarcinoma can arise in many sites. | '''Adenocarcinoma''' is a form of [[cancer]] that arises from glandular tissue. Adenocarcinoma can arise in many sites. | ||
Line 5: | Line 8: | ||
=Types of adenocarcinoma= | =Types of adenocarcinoma= | ||
==Site specific== | ==Site specific== | ||
Below is an incomplete list of adenocarcinomas. | |||
===Gastrointestinal pathology=== | ===Gastrointestinal pathology=== | ||
====Esophagus==== | ====Esophagus==== | ||
Line 44: | Line 48: | ||
====Cervix==== | ====Cervix==== | ||
*[[Endocervical adenocarcinoma]]. | |||
*[[Villoglandular adenocarcinoma of the cervix]]. | *[[Villoglandular adenocarcinoma of the cervix]]. | ||
*[[Minimal deviation adenocarcinoma of the uterine cervix]]. | |||
===Genitourinary pathology=== | ===Genitourinary pathology=== | ||
Line 67: | Line 73: | ||
*Gland forming - round/ovoid/tubular spaces. | *Gland forming - round/ovoid/tubular spaces. | ||
*Eccentric nucleus. | *Eccentric nucleus. | ||
*Moderate cytoplasm. | *Moderate cytoplasm +/- vacuoles. | ||
*+/-Prominent nucleolus. | *+/-Prominent nucleolus. | ||
*+/-[[Nuclear atypia]] - dependent on type/site. | *+/-[[Nuclear atypia]] - dependent on type/site. | ||
Line 73: | Line 79: | ||
DDx: | DDx: | ||
*Carcinoma (poorly differentiated). | *Carcinoma (poorly differentiated). | ||
*[[Sarcoma]]. | *[[Sarcoma]], esp. [[epithelioid sarcomas]]. | ||
*Benign glands. | *Benign glands. | ||
**[[Endometriosis]]. | **[[Endometriosis]]. | ||
Line 80: | Line 86: | ||
===Grading=== | ===Grading=== | ||
Special grading systems exists based on the primary site: | |||
*[[Nottingham grade]] for [[invasive breast cancer]] | |||
*[[Prostate cancer grading|WHO grade groups]] for [[prostate cancer]]. | |||
*Others. | |||
Adenocarcinomas are often graded by their glandular component:<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Esophagus_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Esophagus_11protocol.pdf]. Accessed on: 6 April 2012.</ref> | Adenocarcinomas are often graded by their glandular component:<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Esophagus_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Esophagus_11protocol.pdf]. Accessed on: 6 April 2012.</ref> | ||
*Grade 1: >95% of tumour glandular. | *Grade 1: >95% of tumour glandular. | ||
Line 86: | Line 97: | ||
=See also= | =See also= | ||
*[[Carcinoma]]. | |||
*[[Adenocarcinoma in situ]]. | *[[Adenocarcinoma in situ]]. | ||
*[[Pathologic fracture]]. | *[[Pathologic fracture]]. |
edits